Edgar Engleman

Insider Reports History

Entity
Individual
Location
575 High Street, Ste 201, Palo Alto, CA
Signature
/s/ William P. Quinn, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Edgar Engleman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bolt Biotherapeutics, Inc. Director Common Stock 1.82M $1.73M $0.95 Nov 30, 2023 By Vivo Capital Fund VIII, L.P.
Bolt Biotherapeutics, Inc. Director Common Stock 252K $239K $0.95 Nov 30, 2023 By Vivo Capital Surplus Fund VIII, L.P.
Bolt Biotherapeutics, Inc. Director Stock Option (Right to Buy) 25K Jun 12, 2023 Direct

Insider Reports Filed by Edgar Engleman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BOLT Bolt Biotherapeutics, Inc. Nov 29, 2023 4 -$129K 4 Dec 1, 2023 Director
BOLT Bolt Biotherapeutics, Inc. Nov 21, 2023 2 -$1.75K 4 Nov 22, 2023 Director
BOLT Bolt Biotherapeutics, Inc. Nov 16, 2023 6 -$45.7K 4 Nov 20, 2023 Director
BOLT Bolt Biotherapeutics, Inc. Jun 12, 2023 1 $0 4 Jun 14, 2023 Director
BOLT Bolt Biotherapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 10, 2022 Director
BOLT Bolt Biotherapeutics, Inc. Mar 24, 2022 1 $0 4 Mar 28, 2022 Director